Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
Background: Lymph node metastasis is more likely in early-stage breast cancer with lower tumor-infiltrating lymphocyte (TIL) density. Therefore, we investigated the correlation between TILs and lymph node metastasis in cT1 breast cancer patients undergoing surgery and the usefulness of TILs in predicting sentinel lymph node metastasis (SLNM) in cT1N0M0 breast cancer.
Methods: We investigated 332 breast cancer patients who underwent surgery as the first-line treatment after preoperative diagnosis of cT1. A positive diagnosis of SLNM as an indication for axillary clearance was defined as macrometastasis in the sentinel lymph node (SLN) (macrometastasis: tumor diameter >2 mm). Semi-quantitative evaluation of lymphocytes infiltrating the peritumoral stroma as TILs in primary tumor biopsy specimens prior to treatment was conducted.
Results: For SLN biopsy (SLNB), a median of 2 (range, 1-8) SLNs were pathologically evaluated. Sixty cases (19.4%) of SLNM (macrometastasis: 46, micrometastasis: 16) were observed. Metastasis was significantly greater in breast cancers with tumor diameter >10 mm than in those with diameter 10 mm (p = 0.016). Metastasis was significantly associated with lymphatic invasion (p <0.001). These two clinicopathological factors correlated with SLNM even in patients diagnosed with cN0 (tumor size; p=0.017, lymphatic invasion; p=0.002). Multivariate analysis for SLNM predictors revealed lymphatic invasion (p=0.008, odds ratio [OR]=2.522) and TILs (p<0.001, OR=0.137) as independent factors.
Conclusions: Our results suggest a correlation between lymph node metastasis and tumor immune-microenvironment in cT1 breast cancer. TIL density may be a predictor of SLNM in breast cancer without lymph node metastasis on preoperative imaging.
Figure 1
Figure 2
Figure 3
This is a list of supplementary files associated with this preprint. Click to download.
Posted 23 Jun, 2020
On 18 Jun, 2020
Received 16 Jun, 2020
Received 15 Jun, 2020
Received 28 May, 2020
On 26 May, 2020
On 26 May, 2020
On 25 May, 2020
Invitations sent on 25 May, 2020
On 25 May, 2020
On 25 May, 2020
On 24 May, 2020
On 24 May, 2020
On 17 May, 2020
Received 05 May, 2020
Received 05 May, 2020
Received 04 May, 2020
Received 30 Apr, 2020
On 27 Apr, 2020
On 25 Apr, 2020
Invitations sent on 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 21 Apr, 2020
On 20 Apr, 2020
On 20 Apr, 2020
On 20 Apr, 2020
Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
Posted 23 Jun, 2020
On 18 Jun, 2020
Received 16 Jun, 2020
Received 15 Jun, 2020
Received 28 May, 2020
On 26 May, 2020
On 26 May, 2020
On 25 May, 2020
Invitations sent on 25 May, 2020
On 25 May, 2020
On 25 May, 2020
On 24 May, 2020
On 24 May, 2020
On 17 May, 2020
Received 05 May, 2020
Received 05 May, 2020
Received 04 May, 2020
Received 30 Apr, 2020
On 27 Apr, 2020
On 25 Apr, 2020
Invitations sent on 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 24 Apr, 2020
On 21 Apr, 2020
On 20 Apr, 2020
On 20 Apr, 2020
On 20 Apr, 2020
Background: Lymph node metastasis is more likely in early-stage breast cancer with lower tumor-infiltrating lymphocyte (TIL) density. Therefore, we investigated the correlation between TILs and lymph node metastasis in cT1 breast cancer patients undergoing surgery and the usefulness of TILs in predicting sentinel lymph node metastasis (SLNM) in cT1N0M0 breast cancer.
Methods: We investigated 332 breast cancer patients who underwent surgery as the first-line treatment after preoperative diagnosis of cT1. A positive diagnosis of SLNM as an indication for axillary clearance was defined as macrometastasis in the sentinel lymph node (SLN) (macrometastasis: tumor diameter >2 mm). Semi-quantitative evaluation of lymphocytes infiltrating the peritumoral stroma as TILs in primary tumor biopsy specimens prior to treatment was conducted.
Results: For SLN biopsy (SLNB), a median of 2 (range, 1-8) SLNs were pathologically evaluated. Sixty cases (19.4%) of SLNM (macrometastasis: 46, micrometastasis: 16) were observed. Metastasis was significantly greater in breast cancers with tumor diameter >10 mm than in those with diameter 10 mm (p = 0.016). Metastasis was significantly associated with lymphatic invasion (p <0.001). These two clinicopathological factors correlated with SLNM even in patients diagnosed with cN0 (tumor size; p=0.017, lymphatic invasion; p=0.002). Multivariate analysis for SLNM predictors revealed lymphatic invasion (p=0.008, odds ratio [OR]=2.522) and TILs (p<0.001, OR=0.137) as independent factors.
Conclusions: Our results suggest a correlation between lymph node metastasis and tumor immune-microenvironment in cT1 breast cancer. TIL density may be a predictor of SLNM in breast cancer without lymph node metastasis on preoperative imaging.
Figure 1
Figure 2
Figure 3